1Doctoral Program in Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia
2Faculty of Pharmacy, Universitas Muhammadiyah Kalimantan Timur, Indonesia
3Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia
4Directorate General of Pharmacy and Medical Devices, Ministry of Health of the Republic of Indonesia
5Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia
*Corresponding Author E-mail: nanangy@yahoo.com
Online Published on 06 January, 2026.
Identifying drug-related problems (DRPs) and providing recommendations to clinicians for sepsis patients involves various forms of pharmacist oversight aimed at preventing improper treatment and enhancing patient outcomes. The creation of a pharmacist clinical decision support system (CDSS) to identify DRPs in sepsis patients is expected to enhance the pharmaceutical care services provided by pharmacists, enabling effective and prompt intervention within multidisciplinary teams in hospitals, particularly in intensive care units where patients are critically ill and require fast, precise, and optimal services. Method: This study employs a literature review, also known as descriptive analysis, based on existing research data. Results: The findings indicate that the use of CDSS by pharmacists, particularly for sepsis patients, has been shown to improve the role of pharmacists and enhance clinical outcomes for patients. Conclusion: Based on the results and discussions presented, it can be concluded that CDSS is very effective for identifying drug-related problems (DRPs) more quickly and accurately. However, there remain limitations in previous research regarding the comprehensive development of a medication monitoring system by pharmacists based on Clinical Decision Support Systems (CDSS) for sepsis therapy.
Clinical Decision Support System, Drug Related Problems, Sepsis, Intensive Care Unit